ReviewCancer2026

Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy.

David R Gandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.